Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Desulfovibrio-Roseburia antagonism axis dictates interindividual variability in the metabolic response to inulin.

Created on 01 Sep 2026

Authors

Yun Zhang, Zhaoquan Liu, Xiaowei Wang, Zihan Qin, Xiaoyu Ren, Tongxue Zhang, Chuan He, Junfei Gu, Jiajia Jin

Published in

Food & function. Sep 01, 2026. Epub Sep 01, 2026.

Abstract

Prebiotic inulin improves obesity-related metabolic disturbances, yet its clinical efficacy shows marked interindividual heterogeneity. The key microbial players, interspecies interactions, and downstream effector pathways governing differential responsiveness remain poorly defined. This study is aimed at identifying functional bacteria driving response heterogeneity, delineating the underlying mechanisms, and establishing a predictive biomarker system. Humanized obese mice were generated by high-fat diet preconditioning, and donor-specific response differences were recapitulated by one-to-one fecal microbiota transplantation. Causal links were validated via multi-omics integration, in vitro co-culture, in vivo bacterial recolonization/clearance, and independent cohort verification. Response heterogeneity was driven by antagonism between Desulfovibrio desulfuricans and Roseburia intestinalis. H2S derived from D. desulfuricans directly suppressed R. intestinalis growth and butyrate production, and this microbial interaction axis was functionally relevant to the heterogeneous metabolic responses to inulin. An inulin response index (IRI) based on the Roseburia-to-Desulfovibrio abundance ratio prospectively predicted responder phenotypes. D. desulfuricans gavage markedly attenuated inulin benefits in high-responder microbiota-colonized mice, while sodium molybdate-mediated H2S inhibition, R. intestinalis or sodium butyrate supplementation restored metabolic benefits in low-responder microbiota-colonized mice. Butyrate conferred protection by strengthening gut barrier function, activating GLP-1/PYY secretion, and suppressing adipose inflammation. We uncover a novel D. desulfuricans-H2S-R. intestinalis-butyrate antagonistic axis that mechanistically explains inulin response heterogeneity, providing a mechanistic rationale for personalized nutrition and supporting a clinically translatable predictive index and targeted intervention strategy.

PMID:
42678246
Bibliographic data and abstract were imported from PubMed on 01 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement